|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| C12Q 1/6883 | (2013.01) | ||
| C12Q 1/68 | (2018.01) | ||
| G01N 33/5094 | (2013.01) | ||
| G01N 33/569 | (2006.01) | ||
| G01N 33/56972 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| C07D 205/04 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3647783 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19204477.4 |
| Date of filing the European patent application | 2013-04-19 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361808406 P | 2013-04-04 | US | |
| 201361811321 P | 2013-04-12 | US | |
| 201361813380 P | 2013-04-18 | US |
| (72) |
BORELL, Hubert , CH
GARDIN, Anne , CH
JIN, Yi , CH
LEGANGNEUX, Eric , CH
UFER, Mike , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION |
| IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION |